Both CPT1A and PPARα expression levels were significantly lower in the T2D group compared to the CON one (P < 0.05, 20.04% lower and P < 0.05, 27.87% lower, respectively). The gene discussed is PPARA; the disease is type 2 diabetes mellitus.